Product logins

Find logins to all Clarivate products below.


Obesity Interventions – Market Insights – Middle East (Supplemental)

The Middle East obesity intervention market will grow through 2026, driven by increasing penetration of bariatric procedures and a growing obese population. Additionally, rapid growth in the intragastric balloon segment will help counteract declines in the gastric band segment, contributing to overall market expansion.

This Medtech 360 Report provides key market metrics for the obesity interventions device market in the Middle East region, including country-level data for major countries and aggregate data for the rest of Middle East, across a 10-year period.

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…